Number of Shares
972,508.00
Current Holdings Value*
$13.11 Mil
% of Portfolio
0.08%
Total Estimate Gain
$-26.36 Mil
% of Total Estimate Gain
-3.35%

T. Rowe Price New Horizons Fund, Inc.'s Viridian Therapeutics Inc Holding Summary

As of 2025-03-31, T. Rowe Price New Horizons Fund, Inc. held 972,508.00 shares of Viridian Therapeutics Inc(VRDN), totaling $13.11 Mil. This investment constitutes 0.08% of their stock portfolio, and T. Rowe Price New Horizons Fund, Inc. now holds 1.19% of the outstanding Viridian Therapeutics Inc(VRDN) stock.

The initial trade took place in 2024Q4. And since then T. Rowe Price New Horizons Fund, Inc. has made 2 purchases of VRDN, at an average price of $17.09, for a total of 45.99 Mil shares. Based on historical transaction data and VRDN's current price of $16.52, T. Rowe Price New Horizons Fund, Inc.'s estimated gain on his VRDN holdings is $-26.36 Mil, reflecting a -3.35% gain to date.

T. Rowe Price New Horizons Fund, Inc. VRDN ($16.52) Holding Chart

T. Rowe Price New Horizons Fund, Inc. VRDN ($16.52) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1